Real Estate
Live Price
Offline$2.24
+5.66% today
1Y Change
+60.76%
Window
Jun 20, 2025 โ Jun 16, 2026
Coverage: 248 bars ยท Jun 20, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rafael Holdings, Inc. (RFL) is a Real Estate stock with a market cap of $50.00M and listed on NYSE. The stock last traded around $2.24 and up 60.8% across the available one-year price window (Jun 20, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +44.0%, EPS growth of +28.3%, a dividend yield of 0.0%. What stands out right now is revenue +44.0%, EPS +28.3%, free cash flow -137.2% with operating margin -3050.0% and ROIC -37.6%. Valuation already assumes a fairly strong business story at price/sales 39.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RFL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Real Estate peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+44.0% vs +11.4% peer median
Operating Margin
Below sector median
-3050.0% vs +59.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Jun 10, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +44.0% and EPS at +28.3%, with operating margin around -3050.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -10.3% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Jun 10, 2026 | โ | +19.1% | โ | โ |
2026 Mar 16, 2026 | โ | +0.8% | -3.8% | -2.3% |
2025 Dec 11, 2025 | โ | -2.0% | -16.8% | -16.8% |
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RFL
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RFL Max Drawdown
-49.12%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for RFL and SPY.

Company Overview
Rafael Holdings, Inc.
New York Stock Exchange
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.